首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >New potent human acetylcholinesterase inhibitors in the tetracyclic triterpene series with inhibitory potency on amyloid beta aggregation.
【24h】

New potent human acetylcholinesterase inhibitors in the tetracyclic triterpene series with inhibitory potency on amyloid beta aggregation.

机译:四环三萜系列中的新型有效人乙酰胆碱酯酶抑制剂,对淀粉样β聚集具有抑制作用。

获取原文
获取原文并翻译 | 示例
           

摘要

New acetylcholinesterase inhibitors in the tetracyclic triterpene series were synthesized, tested in vitro for the inhibition of cholinesterases (different sources of AChE and BuChE) and for the ability to prevent AChE-induced Abeta aggregation. Some compounds have hAChE IC50 values in the nanomolar range and showed ability to block the AChE-induced Abeta aggregation. The mode of interaction between EeAChE and compounds 1 and 36e was investigated using docking and molecular dynamics simulations. These studies suggested that both compounds interact simultaneously with the catalytic and the peripheral sites of AChE, and the nature of protein-ligand interactions is mainly hydrophobic.
机译:合成了四环三萜系列中的新型乙酰胆碱酯酶抑制剂,在体外测试了其对胆碱酯酶(AChE和BuChE的不同来源)的抑制作用以及其预防AChE诱导的Abeta聚集的能力。一些化合物的hAChE IC50值在纳摩尔范围内,显示出阻止AChE诱导的Abeta聚集的能力。使用对接和分子动力学模拟研究了EeAChE与化合物1和36e之间的相互作用模式。这些研究表明,两种化合物同时与AChE的催化位点和外围位点相互作用,并且蛋白质-配体相互作用的性质主要是疏水性的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号